Short Interest in Fresenius Medical Care AG (NYSE:FMS) Drops By 24.5%

Fresenius Medical Care AG (NYSE:FMS) saw a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 607,700 shares, a decline of 24.5% from the January 31st total of 804,400 shares. Based on an average daily trading volume, of 253,200 shares, the days-to-cover ratio is currently 2.4 days.

Fresenius Medical Care Stock Up 4.1 %

Fresenius Medical Care stock opened at $23.78 on Thursday. The company’s 50 day simple moving average is $23.49 and its 200 day simple moving average is $21.96. Fresenius Medical Care has a fifty-two week low of $17.93 and a fifty-two week high of $25.25. The firm has a market capitalization of $13.95 billion, a price-to-earnings ratio of 19.65, a PEG ratio of 0.76 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on FMS shares. Truist Financial lifted their price target on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Berenberg Bank assumed coverage on shares of Fresenius Medical Care in a research note on Wednesday, November 6th. They set a “buy” rating and a $25.60 price objective on the stock. Bank of America raised shares of Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research note on Monday, December 2nd. Finally, StockNews.com raised shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of FMS. Millennium Management LLC lifted its stake in Fresenius Medical Care by 5,297.5% in the fourth quarter. Millennium Management LLC now owns 722,238 shares of the company’s stock valued at $16,351,000 after buying an additional 708,857 shares in the last quarter. ABC Arbitrage SA bought a new position in Fresenius Medical Care in the fourth quarter valued at approximately $4,215,000. OLD Mission Capital LLC bought a new position in Fresenius Medical Care in the fourth quarter valued at approximately $3,545,000. Broyhill Asset Management bought a new position in Fresenius Medical Care in the fourth quarter valued at approximately $3,412,000. Finally, Integral Health Asset Management LLC lifted its stake in Fresenius Medical Care by 33.3% in the fourth quarter. Integral Health Asset Management LLC now owns 600,000 shares of the company’s stock valued at $13,584,000 after buying an additional 150,000 shares in the last quarter. Institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.